Hamps Bio Limited (BOM:544312)
26.44
+1.25 (4.96%)
At close: May 27, 2026
Hamps Bio Market Cap
Hamps Bio has a market cap or net worth of 230.35 million as of May 27, 2026.
Market Cap
230.35M
Enterprise Value
257.27M
Revenue
71.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.44
Market Cap Chart
Since December 20, 2024, Hamps Bio's market cap has decreased from 443.18M to 230.35M, a decrease of -48.02%. That is a compound annual growth rate of -36.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 219.46M | 25.95% |
| Dec 29, 2025 | 174.24M | -51.61% |
| Dec 31, 2024 | 360.11M | -18.74% |
| Dec 20, 2024 | 443.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Welcure Drugs and Pharmaceuticals | 358.42M |
| Murae Organisor | 353.20M |
| Walpar Nutritions | 325.85M |
| Deccan Health Care | 305.70M |
| JFL Life Sciences | 305.21M |
| Gujarat Terce Laboratories | 261.16M |
| Rekvina Laboratories | 219.72M |
| Cian Healthcare | 206.47M |